NCT01163825View on ClinicalTrials.gov

Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients

PHASE1UnknownINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2011

Conditions
Alzheimer's Disease
Interventions
DRUG

Nerve Growth Factor

Encapsulated cell biodelivery of Nerve Growth Factor (NGF) to the basal forebrain nuclei of the brain by multiple implantable devices housing NGF-secreting human cells

Trial Locations (1)

17176

Karolinska University Hospital, Stockholm

Sponsors

Lead Sponsor

NsGene A/S
All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

collaborator

Region Stockholm

OTHER_GOV

lead

NsGene A/S

INDUSTRY